LP, G., PA, R., MA, H., JM, A., SA, J., GT, G., . . . SD, N. (2023). Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease. American journal of nephrology, 54(3-4), 126. https://doi.org/10.1159/000530988
Chicago Style (17th ed.) CitationLP, Gregg, et al. "Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease." American Journal of Nephrology 54, no. 3-4 (2023): 126. https://doi.org/10.1159/000530988.
MLA (9th ed.) CitationLP, Gregg, et al. "Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease." American Journal of Nephrology, vol. 54, no. 3-4, 2023, p. 126, https://doi.org/10.1159/000530988.